Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule

Gynecologic Oncology
Takafumi ToitaCervical Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology Group (JGOG)

Abstract

A multicenter phase II trial was conducted to assess the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) with high-dose-rate intracavitary brachytherapy (HDR-ICBT) using a low cumulative prescribed dose schedule in patients with locally advanced uterine cervical cancer. The Japanese Gynecologic Oncology Group (JGOG) study JGOG1066 enrolled patients with FIGO stages III-IVA uterine cervical cancer who had no para-aortic lymphadenopathy (>10 mm) assessed by CT. Patients received definitive radiotherapy (RT) consisting of external beam whole pelvic RT and HDR-ICBT. The cumulative linear quadratic equivalent dose (EQD2) was 62-65 Gy prescribed at point A. Cisplatin 40 mg/m(2) weekly was administered concurrently with RT for 5 courses. Of the 72 patients registered, 71 were eligible. With a median follow-up of 28 months, the 2-year progression-free survival rate and pelvic disease progression-free rate were 66% (95% CI, 54% to 76%) and 73% (95% CI, 61% to 82%), respectively. Progression-free survival decreased significantly with increased central tumor size (P=0.036). The 2-year cumulative late complication rates were 24% for all grades, 9% for grade 1, 12% for grade 2, 3% for grade 3, and 0 for grades 4/5. The JGOG1066...Continue Reading

References

Nov 15, 1993·International Journal of Radiation Oncology, Biology, Physics·L SouhamiC R Freeman
Jul 23, 2003·International Journal of Radiation Oncology, Biology, Physics·Takafumi ToitaSadayuki Murayama
Oct 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rachelle LancianoDennis M O'Connor
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkWui-Jin Koh
Jan 15, 2008·International Journal of Radiation Oncology, Biology, Physics·Takafumi ToitaTeruki Teshima
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration
May 29, 2009·International Journal of Radiation Oncology, Biology, Physics·Christopher J AnkerDavid K Gaffney
May 29, 2009·International Journal of Radiation Oncology, Biology, Physics·Kailash NarayanSrinivas Kondalsamy-Chennakesavan
Jul 22, 2009·International Journal of Radiation Oncology, Biology, Physics·Akila N Viswanathan, Beth A Erickson
Aug 15, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Johannes C A DimopoulosChristian Kirisits
Dec 25, 2010·International Journal of Radiation Oncology, Biology, Physics·Akila N ViswanathanEdward Trimble
Feb 19, 2011·International Journal of Clinical Oncology·Takafumi ToitaUNKNOWN Disease Committee of Radiation Oncology, Japanese Gynecologic Oncology Group
Jun 7, 2011·International Journal of Radiation Oncology, Biology, Physics·Adeline Lim, Serena Sia

❮ Previous
Next ❯

Citations

Nov 5, 2013·Gynecologic Oncology·Masaru WakatsukiUNKNOWN Working Group of the Gynecological Tumor
Feb 25, 2014·Journal of Radiation Research·Masashi ChataniRika Tachimoto
Oct 19, 2014·Current Oncology Reports·Keiichi FujiwaraMojgan Devouassoux-Shisheboran
Jun 4, 2014·The Journal of Obstetrics and Gynaecology Research·Yumi YanazumeTsutomu Douchi
Jan 16, 2015·Journal of Radiation Research·Masaru WakatsukiUNKNOWN Working Group of the Gynecological Tumor
Jul 24, 2013·Gynecologic Oncology·Masaharu HataTomio Inoue
May 21, 2015·PloS One·Masaru WakatsukiUNKNOWN Working Group of the Gynecological Tumor
Feb 23, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Oyeon ChoMison Chun
Aug 31, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Takafumi ToitaUNKNOWN Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group
May 6, 2020·Journal of Radiation Research·Noriyuki OkonogiUNKNOWN Forum for Nuclear Cooperation in Asia
Sep 29, 2020·Palliative & Supportive Care·Hideki OnishiMayumi Ishida
Oct 7, 2018·International Journal of Clinical Oncology·Yasuhiko EbinaDaisuke Aoki
Aug 31, 2018·Japanese Journal of Clinical Oncology·Shintaro YanazumeHiroaki Kobayashi
Jul 26, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Keiko Nemoto MurofushiHideyuki Sakurai
Oct 16, 2015·Journal of Gynecologic Oncology·Reiko KobayashiKeiichi Nakagawa
Mar 14, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Keiko MurofushiHideyuki Sakurai
Oct 27, 2018·The Cochrane Database of Systematic Reviews·Komsan ThamronganantasakulPisake Lumbiganon
Sep 12, 2019·Brachytherapy·Daijiro KobayashiTadashi Kamada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Takafumi ToitaCervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group
© 2021 Meta ULC. All rights reserved